Navigation Links
Blood-Thinner Plavix Works Harder in Smokers
Date:8/4/2008

But the finding certainly isn't any reason to start or continue smoking, researchers say

MONDAY, Aug. 4 (HealthDay News) -- The widely used anti-clotting drug Plavix appears to have a stronger effect in people who smoke, a study indicates.

Plavix (clopidogrel) is often given to heart attack patients after the attack. It inhibits formation of clots by blood cells called platelets.

The study of 259 people given Plavix because of coronary conditions found that those who smoked had significantly less clot formation than nonsmokers.

But it's still too early to say that doctors should include smoking among the factors that affect whether Plavix should be prescribed or how large the dose should be, said study lead author Dr. Paul A. Gurbel, associate professor of medicine at Johns Hopkins University and director of the Sinai Center for Thrombosis Research, Baltimore.

"I don't know if we can jump to that conclusion yet," Gurbel said. "We need to study this further. We do know from two large-scale clinical trials that smokers benefited more when they got Plavix therapy. Maybe smoking does something to make Plavix work better."

That "something" probably occurs in the liver, where the drug is metabolized, Gurbel said. Cigarette smoking increases the production of CYP1A2, a liver enzyme that converts the drug to its active form, he said.

"Current smoking was an independent predictor of low platelet aggregation," the journal report said.

Of course, lower clotting action can sometimes mean a higher risk for bleeding. But Gurbel said that, based on these early findings, "we don't know if [smoking patients] will bleed more."

The findings were expected to be published in the Aug. 12 issue of the Journal of the American College of Cardiology.

Plavix is widely used to prevent coronary problems and is commonly prescribed after a heart attack. A standard recommendation for heart attack patients includes a year of combined therapy with Plavix and aspirin, another clot-preventing drug.

The indication that smoking reduces platelet stickiness in people given Plavix "is certainly observational at this point" and requires proof in a large, controlled trial, Gurbel said.

"Were trying to get funding for a trial right now," he said.

The trial he envisions would enroll a large group of smokers who would all be prescribed Plavix. "Then we would remove the smoking in half the group," Gurbel said. "We would see whether that removal adds support for our observation."

The hardest part of such a trial would be to get half a group of smokers to quit, Gurbel acknowledged.

"And were definitely not telling people to smoke if they have heart disease," he said. Smoking is high on the list of risk factors for heart attack, stroke and other cardiovascular problems, Gurbel noted.

The study was funded in part by a grant from drug maker Daiichi Sankyo Inc.

More information

For move on Plavix, head to the U.S. National Library of Medicine.



SOURCES: Paul A. Gurbel, M.D., director, Sinai Center for Thrombosis Research, Baltimore; Aug. 12, 2008, Journal of the American College of Cardiology


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Blood-Thinner No Help for Dialysis Treatment
2. Blood-Thinner Contaminant Traced to Chinese Plant
3. Mix-Up Behind FDAs Failure to Inspect China Blood-Thinner Plant
4. First 90 Days After Stopping Plavix Most Dangerous
5. Once-Daily Combo Works for New HIV Patients
6. Plexus Consulting Group Works With a USAID-Funded Project to Help the Private Hospitals Association of Jordan Create a Roadmap for the Future
7. Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop
8. DIA And FDA To Host Two Important Critical Path Workshops
9. Autisms social struggles due to disrupted communication networks in brain
10. Ceridian LifeWorks Offers CareGiverHelper Service to Clients to Ease Stress of Family Caregiving
11. Workshop Helps Parents, Kids Talk About Sex
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood-Thinner Plavix Works Harder in Smokers
(Date:4/21/2017)... , ... April 21, 2017 , ... The Hong Kong ... first 3D printing facility among higher education institutions in Hong Kong to support teaching, ... terms of the range and quantity of facilities in Hong Kong. , With ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Alive ... people who wish to overcome their mental health struggles. The Alive team uses ... LeBouthillier says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... category of International Trade, the UK’s most prestigious award for business success. ... 95% of total revenues and has grown by a total of 400% over ...
(Date:4/21/2017)... ... April 21, 2017 , ... BrightStar Care Salt Lake City, a home care ... Utah (APCUT) and has appointed Rex Wheeler as its new Director of Business Development. ... agency and our ability to provide quality care to the community,” said Tammara Brown, ...
(Date:4/21/2017)... Miami, Fl (PRWEB) , ... April 21, 2017 , ... ... Earth Day is a day to clean, plant trees and look forward to a ... green isn’t just about doing something outdoors. Indoor air quality can be two to ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, ... on providing the Urology, Uro/Gyn and Gynecology markets with ... the first quarter ended March 31, 2017 after the ... The Company will host a conference call and ... on Tuesday, May 2, 2017 at 4:30 p.m. Eastern ...
(Date:4/18/2017)...  Socionext Inc. and SOINN Inc. today announced ... which Socionext extracts and delivers biometrics data to ... results in reading ultrasound images from Socionext,s viewphii™ ... results will be introduced at Medtec Japan, held ... 4505 & 4507. In this initial ...
Breaking Medicine Technology: